UCB - Ebit

Stock Price
261.00
Daily Change
0.40 0.15%
Monthly
11.11%
Yearly
41.46%
Q1 Forecast
249.19

UCB reported EUR502M in EBIT for its fiscal semester ending in December of 2024.





Ebit Change Date
Alcon AG USD 334M 84M Sep/2025
Almirall EUR 43.02M 28.78M Jun/2025
Amarin USD -1.7M 8.47M Sep/2025
argenx SE USD 349.97M 61.94M Sep/2025
AstraZeneca USD -1.5B 5.01B Sep/2025
Bayer EUR -399M 363M Sep/2025
Galapagos EUR -41.67M 15.35M Sep/2025
Genmab DKK 432M 900.27M Jun/2025
GlaxoSmithKline GBP 2.79B 716M Sep/2025
GRIFOLS EUR 352.11M 20.18M Sep/2025
Hikma Pharmaceutical USD 317M 85M Dec/2024
Lonza CHF 673M 54M Jun/2025
Merck EUR 1.21B 180M Sep/2025
Novartis USD -9.19B 13.87B Jun/2025
Orion EUR 104.6M 26.7M Jun/2025
Recordati EUR 165.64M 21.71M Sep/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
UCB EUR 502M 168M Dec/2024
Unibail Rodamco EUR 1.13B 41.8M Dec/2024